Liver resection using bipolar InLine multichannel radiofrequency device: Impact on intra- and peri-operative outcomes

R. Daylami, H. Kargozaran, V. P. Khatri

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims: Liver resection is indicated for several primary and secondary liver lesions. We follow up our earlier experience with the use of InLine Multichannel Radiofrequency Device (ILMRD, Resect Medical Inc., Fremont, CA) a device that produces coagulative necrosis along the transection plane. Methods: The records of 68 consecutive patients who underwent liver resection for primary and metastatic liver tumors from August 2000 to December 2008 were reviewed. Data analyzed include demographic data as well as complexity of liver resection, intra-operative blood loss, use of portal triad clamping and transfusion of blood. Postoperative outcomes measured were morbidity, hospital and ICU length of stay. Results: The median estimated blood loss was 150 mL in the ILMRD group compared to 400 mL in the non-ILMRD group (p < 0.0001). Median length of stay was decreased in the ILMRD group by a day (7 vs. 8 p < 0.003). There was a significant decrease in frequency of parenchymal clamp time (57% vs 84%, p < 0.001) and median total portal triad clamp time (2.5 vs 30 min p < 0.0001). We also noted a significant decrease in the median portal triad clamp time (0 vs 25 min, p < 0.001) used during the parenchymal transection phase. Furthermore, use of the ILMRD device allowed us to perform more complex hepatic resections. Conclusion: Use of ILMRD to perform radiofrequency-assisted hepatic resection was associated with a significant decrease in intra-operative blood loss and earlier discharge from the hospital despite increasing complexity of resections and decreased use of portal triad clamping.

Original languageEnglish (US)
Pages (from-to)531-536
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume38
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Equipment and Supplies
Liver
Constriction
Length of Stay
Blood Transfusion
Necrosis
Demography
Morbidity
Neoplasms

Keywords

  • Liver resection
  • Portal triad clamping
  • Radiofrequency assisted

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Liver resection using bipolar InLine multichannel radiofrequency device : Impact on intra- and peri-operative outcomes. / Daylami, R.; Kargozaran, H.; Khatri, V. P.

In: European Journal of Surgical Oncology, Vol. 38, No. 6, 06.2012, p. 531-536.

Research output: Contribution to journalArticle

@article{98bb5d1872d742b7b55aa69d1a1a483f,
title = "Liver resection using bipolar InLine multichannel radiofrequency device: Impact on intra- and peri-operative outcomes",
abstract = "Aims: Liver resection is indicated for several primary and secondary liver lesions. We follow up our earlier experience with the use of InLine Multichannel Radiofrequency Device (ILMRD, Resect Medical Inc., Fremont, CA) a device that produces coagulative necrosis along the transection plane. Methods: The records of 68 consecutive patients who underwent liver resection for primary and metastatic liver tumors from August 2000 to December 2008 were reviewed. Data analyzed include demographic data as well as complexity of liver resection, intra-operative blood loss, use of portal triad clamping and transfusion of blood. Postoperative outcomes measured were morbidity, hospital and ICU length of stay. Results: The median estimated blood loss was 150 mL in the ILMRD group compared to 400 mL in the non-ILMRD group (p < 0.0001). Median length of stay was decreased in the ILMRD group by a day (7 vs. 8 p < 0.003). There was a significant decrease in frequency of parenchymal clamp time (57{\%} vs 84{\%}, p < 0.001) and median total portal triad clamp time (2.5 vs 30 min p < 0.0001). We also noted a significant decrease in the median portal triad clamp time (0 vs 25 min, p < 0.001) used during the parenchymal transection phase. Furthermore, use of the ILMRD device allowed us to perform more complex hepatic resections. Conclusion: Use of ILMRD to perform radiofrequency-assisted hepatic resection was associated with a significant decrease in intra-operative blood loss and earlier discharge from the hospital despite increasing complexity of resections and decreased use of portal triad clamping.",
keywords = "Liver resection, Portal triad clamping, Radiofrequency assisted",
author = "R. Daylami and H. Kargozaran and Khatri, {V. P.}",
year = "2012",
month = "6",
doi = "10.1016/j.ejso.2012.02.181",
language = "English (US)",
volume = "38",
pages = "531--536",
journal = "Clinical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Liver resection using bipolar InLine multichannel radiofrequency device

T2 - Impact on intra- and peri-operative outcomes

AU - Daylami, R.

AU - Kargozaran, H.

AU - Khatri, V. P.

PY - 2012/6

Y1 - 2012/6

N2 - Aims: Liver resection is indicated for several primary and secondary liver lesions. We follow up our earlier experience with the use of InLine Multichannel Radiofrequency Device (ILMRD, Resect Medical Inc., Fremont, CA) a device that produces coagulative necrosis along the transection plane. Methods: The records of 68 consecutive patients who underwent liver resection for primary and metastatic liver tumors from August 2000 to December 2008 were reviewed. Data analyzed include demographic data as well as complexity of liver resection, intra-operative blood loss, use of portal triad clamping and transfusion of blood. Postoperative outcomes measured were morbidity, hospital and ICU length of stay. Results: The median estimated blood loss was 150 mL in the ILMRD group compared to 400 mL in the non-ILMRD group (p < 0.0001). Median length of stay was decreased in the ILMRD group by a day (7 vs. 8 p < 0.003). There was a significant decrease in frequency of parenchymal clamp time (57% vs 84%, p < 0.001) and median total portal triad clamp time (2.5 vs 30 min p < 0.0001). We also noted a significant decrease in the median portal triad clamp time (0 vs 25 min, p < 0.001) used during the parenchymal transection phase. Furthermore, use of the ILMRD device allowed us to perform more complex hepatic resections. Conclusion: Use of ILMRD to perform radiofrequency-assisted hepatic resection was associated with a significant decrease in intra-operative blood loss and earlier discharge from the hospital despite increasing complexity of resections and decreased use of portal triad clamping.

AB - Aims: Liver resection is indicated for several primary and secondary liver lesions. We follow up our earlier experience with the use of InLine Multichannel Radiofrequency Device (ILMRD, Resect Medical Inc., Fremont, CA) a device that produces coagulative necrosis along the transection plane. Methods: The records of 68 consecutive patients who underwent liver resection for primary and metastatic liver tumors from August 2000 to December 2008 were reviewed. Data analyzed include demographic data as well as complexity of liver resection, intra-operative blood loss, use of portal triad clamping and transfusion of blood. Postoperative outcomes measured were morbidity, hospital and ICU length of stay. Results: The median estimated blood loss was 150 mL in the ILMRD group compared to 400 mL in the non-ILMRD group (p < 0.0001). Median length of stay was decreased in the ILMRD group by a day (7 vs. 8 p < 0.003). There was a significant decrease in frequency of parenchymal clamp time (57% vs 84%, p < 0.001) and median total portal triad clamp time (2.5 vs 30 min p < 0.0001). We also noted a significant decrease in the median portal triad clamp time (0 vs 25 min, p < 0.001) used during the parenchymal transection phase. Furthermore, use of the ILMRD device allowed us to perform more complex hepatic resections. Conclusion: Use of ILMRD to perform radiofrequency-assisted hepatic resection was associated with a significant decrease in intra-operative blood loss and earlier discharge from the hospital despite increasing complexity of resections and decreased use of portal triad clamping.

KW - Liver resection

KW - Portal triad clamping

KW - Radiofrequency assisted

UR - http://www.scopus.com/inward/record.url?scp=84860274125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860274125&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2012.02.181

DO - 10.1016/j.ejso.2012.02.181

M3 - Article

C2 - 22459903

AN - SCOPUS:84860274125

VL - 38

SP - 531

EP - 536

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0748-7983

IS - 6

ER -